Osteoactiv 3-in-1 Joint Formula Dosage & Drug Information

Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Overdosage Contraindications Special Precautions Use In Pregnancy & Lactation Adverse Reactions Drug Interactions Storage MIMS Class ATC Classification Regulatory Classification Presentation/Packing

Concise Prescribing Info

Contents

Per tab Glucosamine HCl 250 mg, methylsulfonylmethane 250 mg, chondroitin sulfate 200 mg. Per sachet Glucosamine HCl 1,000 mg, methylsulfonylmethane 1,000 mg, chondroitin sulfate 800 mg

Indications/Uses

Adjuvant therapy for OA.

Click to view Osteoactiv 3-in-1 Joint Formula detailed prescribing information

Dosage/Direction for Use

Tab Adult Light or moderate OA symptoms 2 tab bd for at least 6 wk. Severe OA symptoms 2 tab tds for at least 8-12 wk. Maintenance: 2 tab bd for 3-4 mth. Repeat treatment every other ≤6 mth. Powd for oral soln 1 sachet once daily.

Click to view Osteoactiv 3-in-1 Joint Formula detailed prescribing information

Overdosage

View Osteoactiv 3-in-1 Joint Formula overdosage for action to be taken in the event of an overdose.

Administration

Should be taken on an empty stomach.

Special Precautions

Exclude presence of other joint conditions/diseases. Severe hepatic or renal insufficiency. Avoid use during 1st trimester of pregnancy. Lactation. Avoid use in childn.

Click to view Osteoactiv 3-in-1 Joint Formula detailed prescribing information

Use In Pregnancy & Lactation

Click to view Osteoactiv 3-in-1 Joint Formula detailed prescribing information

Adverse Reactions

Peripheral oedema, tachycardia; skin reactions eg, erythema, pruritus.

Click to view Osteoactiv 3-in-1 Joint Formula detailed prescribing information

Drug Interactions

Impaired insulin secretion. Increased insulin resistance. Affected glucose tolerance. Reduced antidiabetic effects of acarbose, acetohexamide, chlorpropamide, glipizide, glyburide, metformin, miglitol, pioglitazone, repaglinide, rosiglitazone, glimepiride, tolbutamide, troglitazone. Reduced effectiveness of doxorubicin, etoposide, teniposide. Potentiated anticoagulant effects of warfarin.

Click to view Osteoactiv 3-in-1 Joint Formula detailed prescribing information

Storage

View Osteoactiv 3-in-1 Joint Formula storage conditions for details to ensure optimal shelf-life.

Description

View Osteoactiv 3-in-1 Joint Formula description for details of the chemical structure and excipients (inactive components).

Action

View Osteoactiv 3-in-1 Joint Formula mechanism of action for pharmacodynamics and pharmacokinetics details.

MIMS Class

Other Drugs Acting on Musculo-Skeletal System

ATC Classification

M09AX - Other drugs for disorders of the musculo-skeletal system ; Used in the treatment of musculo-skeletal disorders.

Regulatory Classification

Presentation/Packing

Form

Osteoactiv 3-in-1 Joint Formula powd for oral soln

Packing/Price

(orange flavour) 4.5 g x 30 × 1's

Form

Osteoactiv 3-in-1 Joint Formula tab

Packing/Price

12 × 10's

Osteoactiv 3-in-1 Joint Formula

Manufacturer:

Winwa Medical

Distributor:

Winwa Medical